21
cfr
part
520
<
doctitleoral
dosage
form
new
animal
drugs
;
proban
&
reg
;
(
cythioate
)
tablets/doctitle
>
<
agency
>
agency
:
food
and
drug
administration
,
hhs
.
<
agency
>
<
action
>
action
:
final
rule
.
<
action
>
<
summary
>
summary
:
the
food
and
drug
administration
(
fda
)
is
amending
the
animal
drug
regulations
to
reflect
approval
of
a
supplemental
new
animal
drug
application
(
nada
)
filed
by
miles
,
inc
.
the
supplemental
nada
provides
for
the
oral
use
of
a
90milligram
milligram
(
mg
)
proban
&
reg
;
(
cythioate
)
tablet
in
addition
to
the
currently
approved
use
of
the
30mg
tablet
.
<
summary
>
<
date
>
effective
date
:
05/25/1994
.
<
date
>
<
further
>
for
further
information
contact
:
marcia
k
.
larkins
,
center
for
veterinary
medicine
(
hfv112
hfv
,
food
and
drug
administration
,
7500
standish
pl
,
rockville
,
md
20855
,
3015940614
.
<
further
>
<
supplem
>
supplementary
information
:
miles
,
inc
,
agriculture
division
,
animal
health
products
,
po
.
box
390
,
shawnee
mission
,
ks
66201
,
filed
supplemental
nada
132337
,
which
provides
for
the
use
of
a
90mg
proban
&
reg
;
(
cythioate
)
tablet
in
addition
to
the
approved
30mg
tablet
for
control
of
fleas
on
dogs
.
the
supplemental
nada
is
approved
as
of
04/25/1994
,
and
the
regulations
are
amended
in
21
cfr
520
531
to
reflect
the
approval
.
approval
of
this
supplement
does
not
require
submission
of
new
safety
or
effectiveness
data
.
this
supplement
provides
for
use
of
a
larger
tablet
with
increased
drug
concentration
to
be
given
at
the
currently
approved
use
level
.
however
,
in
accordance
with
the
freedom
of
information
provisions
of
part
20
(
21
cfr
part
20
)
and
§
514
11
)
(
21
cfr
514
11
,
a
freedom
of
information
summary
is
provided
for
the
revised
labeling
.
under
section
512c2fiii
)
of
the
federal
food
,
drug
,
and
cosmetic
act
(
21
usc
.
360bc2fiii
,
this
approval
does
not
qualify
for
marketing
exclusivity
.
the
additional
studies
submitted
with
the
supplement
were
conducted
as
requested
by
fda
to
correct
deficiencies
in
the
original
data
supporting
safety
and
effectiveness
of
the
1968
approval
,
and
they
were
not
essential
to
the
approval
of
this
supplement
.
the
agency
has
determined
under
21
cfr
25
24
)
that
this
action
is
of
a
type
that
does
not
individually
or
cumulatively
have
a
significant
effect
on
the
human
environment
.
therefore
,
neither
an
environmental
assessment
nor
an
environmental
impact
statement
is
required
.
list
of
subjects
in
21
cfr
part
520
animal
drugs
.
therefore
,
under
the
federal
food
,
drug
,
and
cosmetic
act
and
under
authority
delegated
to
the
commissioner
of
food
and
drugs
and
redelegated
to
the
center
for
veterinary
medicine
,
21
cfr
part
520
is
amended
as
follows
:
part
520oral
dosage
form
new
animal
drugs
1
.
the
authority
citation
for
21
cfr
part
520
continues
to
read
as
follows
:
authority
:
sec
.
512
of
the
federal
food
,
drug
,
and
cosmetic
act
(
21
usc
.
360b
.
2
.
section
520
531
is
amended
by
removing
and
reserving
paragraph
(
a
)
and
by
revising
paragraph
(
b
)
to
read
as
follows
:
§
520
531
cythioate
tablets
.
(
a
)
[
reserved
]
(
b
)
sponsors
.
.
see
no
.
000859
in
§
510
600
)
of
this
chapter
for
use
of
30
-
and
90milligram
milligram
(
mg
)
tablets
and
see
no
.
010042
in
§
510
600
)
of
this
chapter
for
use
of
30mg
tablet
.
*
*
*
*
*
*
*
*
*
*
dated
:
05/16/1994
.
<
supplem
>
<
signer
>
robert
c
.
livingston
,
<
signer
>
<
signjob
>
director
,
office
of
new
animal
drug
evaluation
,
center
for
veterinary
medicine
.
<
signjob
>
<
frfiling
>
[
fr
doc
.
9412664
filed
05/24/1994
;
845
am
]
<
frfiling
>
<
billing
>
billing
code
416001f
<
billing
>
<
text
>
